PFIZER INC (PFE)
Pharmaceutical Preparations · Pharmaceutical Preparations · NYSE
$28.24
+3.63%
Investingg Score
45.6 / 100
Sell
Business overview
- Gross margin of 74.3%
- Revenue growth YoY of -1.6%
The high gross margin is offset by negative revenue growth, indicating mixed business quality.
Financial health
- Free cash flow margin of 14.5%
- Operating margin data unavailable
Positive free cash flow supports financial health, but the lack of operating margin information adds uncertainty.
- Gross Margin
- 74.3%
- Operating Margin
- Data unavailable
- Current Ratio
- 1.2x
- Debt / Equity
- 0.71
- Free Cash Flow (TTM)
- $9.1B
- Interest Coverage
- Data unavailable
Valuation
- Forward P/E ratio of 8.64
- PS ratio of 0 (not applicable)
The forward P/E suggests a low valuation relative to earnings, while the PS ratio provides no insight.
- P/E (TTM)
- Data unavailable
- Forward P/E
- 8.6x
- Price / Sales
- 0.0x
- EV / EBITDA
- Data unavailable
- FCF Yield
- Data unavailable
Key risks
- Revenue decline
- High RSI indicating overbought conditions
- Lack of operating margin data
Market cap $0 · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze PFE with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.